Zeng Wenfeng, Zhang Ruihua, Huang Penghan, Chen Minxia, Chen Houying, Zeng Xin, Liu Jiang, Zhang Jiahui, Huang Di, Lao Liyan
Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Medical Research Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China.
Breast Tumor Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China.
Cancer Res. 2025 Feb 1;85(3):477-496. doi: 10.1158/0008-5472.CAN-24-1941.
Inducing ferroptosis in tumor cells is emerging as a strategy for treating malignancies that are refractory to traditional treatment modalities. However, the consequences of ferroptosis of immune cells in the tumor microenvironment need to be better understood in order to realize the potential of this approach. In this study, we discovered that neutrophils in chemoresistant breast cancer are highly sensitive to ferroptosis. Reduction of the acyltransferase MOAT1 in chemoresistance-associated neutrophils induced phospholipid reprogramming, switching the preference from monounsaturated fatty acids to polyunsaturated fatty acids, which increased their susceptibility to ferroptosis. Ferroptotic neutrophils secreted PGE2, IDO, and oxidized lipids that suppressed the proliferation and cytotoxicity of antitumor CD8+ T cells. Furthermore, neutrophil ferroptosis was closely related to a distinct subset of IL1β+CXCL3+CD4+ (Fer-CD4) T lymphocytes, which were enriched in chemoresistant tumors. Fer-CD4 T cells orchestrated neutrophil ferroptosis by modulating MOAT1 expression via IL1β/IL1R1/NF-κB signaling. Moreover, Fer-CD4 T cells secreted CXCL3, IL8, and S100A9 to replenish the neutrophil pool in the tumor microenvironment. Ferroptotic neutrophils in turn fostered Fer-CD4 T-cell differentiation. In spontaneous tumorigenesis mouse models, targeting IL1β+ CD4+ T cells or IL1R1+ neutrophils broke the cross-talk, restraining neutrophil ferroptosis, enhancing antitumor immunity, and overcoming chemoresistance. Overall, these findings uncover the role of neutrophil ferroptosis in shaping the immune landscape and propose appealing targets for restoring immunosurveillance and chemosensitivity in breast cancer. Significance: In chemoresistant breast cancer, IL1β+CXCL3+CD4+ T cells mediate neutrophil ferroptosis that suppresses antitumor immunity, indicating that interfering with this intercellular cross-talk could be an attractive strategy to reverse chemoresistance.
诱导肿瘤细胞发生铁死亡正在成为一种治疗对传统治疗方式难治的恶性肿瘤的策略。然而,为了实现这种方法的潜力,需要更好地了解肿瘤微环境中免疫细胞铁死亡的后果。在本研究中,我们发现化疗耐药乳腺癌中的中性粒细胞对铁死亡高度敏感。化疗耐药相关中性粒细胞中酰基转移酶MOAT1的减少诱导了磷脂重编程,将偏好从单不饱和脂肪酸转变为多不饱和脂肪酸,这增加了它们对铁死亡的易感性。铁死亡的中性粒细胞分泌PGE2、IDO和氧化脂质,抑制抗肿瘤CD8+T细胞的增殖和细胞毒性。此外,中性粒细胞铁死亡与IL1β+CXCL3+CD4+(Fer-CD4)T淋巴细胞的一个独特亚群密切相关,该亚群在化疗耐药肿瘤中富集。Fer-CD4 T细胞通过IL1β/IL1R1/NF-κB信号通路调节MOAT1表达来协调中性粒细胞铁死亡。此外,Fer-CD4 T细胞分泌CXCL3、IL8和S100A9以补充肿瘤微环境中的中性粒细胞池。铁死亡的中性粒细胞反过来促进Fer-CD4 T细胞分化。在自发肿瘤发生小鼠模型中,靶向IL1β+CD4+T细胞或IL1R1+中性粒细胞打破了这种相互作用,抑制中性粒细胞铁死亡,增强抗肿瘤免疫力,并克服化疗耐药性。总体而言,这些发现揭示了中性粒细胞铁死亡在塑造免疫格局中的作用,并为恢复乳腺癌的免疫监视和化疗敏感性提出了有吸引力的靶点。意义:在化疗耐药乳腺癌中,IL1β+CXCL3+CD4+T细胞介导抑制抗肿瘤免疫的中性粒细胞铁死亡,表明干扰这种细胞间相互作用可能是逆转化疗耐药性的有吸引力策略。